Mr. Barry managed the compliance requirements of participating foreign countries and was tasked with the direct oversight of minimizing the impact of illicit drugs on the United States under Letters of Agreements with respective foreign U.S. Embassies. Tim’s experience of taking stringent drug laws and regulations, and turning them into tangible effective processes, procedures, and programs designed to ensure compliance, will help develop and establish the compliance protocols ACC uses to advise its clients.
ACC will begin by offering these services to clients in Colorado, which includes conducting reviews of cultivation, processing, and dispensary locations, to help ensure they are meeting state regulatory requirements and operating with best practices. As more states continue to adopt and evolve their regulatory framework, maintaining compliance becomes more and more demanding. ACC is excited to launch this program as it is very closely aligned with the Company’s vision statement changing society’s relationship with cannabis through responsible stewardship.
“American Cannabis Company is extremely excited to partner with Mr. Barry as we expand the Company’s compliance services,” said Corey Hollister, CEO of American Cannabis Company. “Mr. Barry’s background will provide valuable insight for the company and it’s clients.”
About American Cannabis Company:
American Cannabis Company (“ACC”) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and The Trade Winds, a group purchasing organization, we support our clients from concept to creation to commercialization.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visitwww.sec.gov.
Chief Operating Officer
SOURCE: American Cannabis Company, Inc.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | email@example.com